

share
Chromomycinone CAS NO 10183-93-4
Unit Price:
CAS No.:10183-93-4
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Chromomycinone is a key chemical intermediate and aglycone moiety derived from the chromomycin family of antibiotics. This compound matters for its role as a fundamental building block in the research and synthesis of complex bioactive molecules, particularly antitumor agents. It is needed by pharmaceutical R&D laboratories, academic research institutions, and fine chemical manufacturers focused on developing novel therapeutic compounds and studying natural product biosynthesis.
Application
- Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis and semi-synthesis of chromomycin antibiotics and related analogs.
- Anticancer Research: Used as a reference standard and starting material in the development and study of new chemotherapeutic agents targeting DNA.
- Biochemical Research: Employed in studies investigating the mechanism of action of aureolic acid family antibiotics and their interaction with nucleic acids.
- Microbiology Studies: Applied in research exploring the biosynthesis pathways of microbial secondary metabolites.
- Organic Synthesis: Utilized as a complex scaffold for the preparation of novel chemical entities in medicinal chemistry programs.
Basic Information
| Product Name | Chromomycinone |
| CAS No. | 10183-93-4 |
| Molecular Formula | C21H20O8 |
| Molecular Weight | 400.38 g/mol |
| Synonyms | Chromomycin A3 aglycone; 2,4,6,8-Tetrahydroxy-3-methyl-11-oxo-11H-naphtho[2,1-b]pyran-5-carboxylic acid; 5-De(2,6-dideoxy-4-O-methyl-α-L-lyxo-hexopyranosyl)-chromomycin A3; Chromomycinone aglycone; Aureolic acid aglycone |
| EINECS | Contact for details |
Quality Control
Our Chromomycinone is produced under strict quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and development applications. A detailed Certificate of Analysis (COA) is provided with every shipment to guarantee traceability and batch-to-batch consistency.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container sealed to protect from moisture.
Specification
| Item | Specification |
|---|---|
| Appearance | Yellow to brownish-yellow powder |
| Identification (HPLC) | Conforms to reference standard |
| Identification (IR) | Conforms to structure |
| Purity (HPLC) | ≥ 95.0% |
| Loss on Drying | ≤ 2.0% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


1,3-Dihydroxy-2-Methylanthraquinone CAS NO 117-02-2


1,5-Dihydroxyanthraquinone CAS NO 117-12-4


1-Hydroxy Anthraquinone CAS NO 129-43-1


Peonidin Chloride CAS NO 134-01-0


Apigeninidin Chloride CAS NO 1151-98-0


Malvidin CAS NO 1329-33-5


Aloin CAS NO 1415-73-2


1,4-Dimethylanthraquinone CAS NO 1519-36-4


Cassiamina CAS NO 1828-75-7


Versicolorins CAS NO 10088-98-9


1,3,8-Trihydroxy-6-Methoxy-2-(1-Oxohexyl)-9,10-Anthraquinone CAS NO 10210-21-6


Norsolorinicacid CAS NO 10254-99-6


2-Amino-1-Nitroanthraquinone CAS NO 10262-82-5


3-Hydroxy-1,2-Dimethoxy-Anthraquinone CAS NO 10383-62-7


Anthraquinone, 1,3-Dihydroxy-2-Methoxy- CAS NO 10383-63-8


Malvidin CAS NO 10463-84-0


Aloinoside B CAS NO 11006-91-0


Senfolomycin B CAS NO 11031-56-4


(-)-1',4,5,6,7',8'-Hexahydroxy-2,3'-Dimethyl-1,2'-Bi[9,10-Anthraquinone] CAS NO 11032-85-2


Delphinidin CAS NO 13270-61-6
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






